TCG Crossover Management »

Vistagen Therapeutics shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Vistagen Therapeutics shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Vistagen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vistagen Therapeutics held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vistagen Therapeutics by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $9.3M 2.7M 3.48
2024-03-31 $14M 2.7M 5.28
2023-12-31 $14M 2.7M 5.14

More positions owned by TCG Crossover Management

Cg Oncology Comm (CGON)
Dyne Therapeutics Comm (DYN)
Abivax SA Adrs (ABVX)
Silence Therapeutics Adrs (SLN)
Cogent Biosciences Comm (COGT)
Savara Comm (SVRA)
Madrigal Pharmaceuticals Comm (MDGL)
Edgewise Therapeutics Comm (EWTX)
Keros Therapeutics Comm (KROS)
Mineralys Therapeutics Comm (MLYS)
Ocular Therapeutix Comm (OCUL)
Tyra Biosciences Comm (TYRA)
Kura Oncology Comm (KURA)
Structure Therapeutics Adrs (GPCR)
Centessa Pharmaceuticals Comm (CNTA)

View all positions for TCG Crossover Management

Top funds holding Vistagen Therapeutics

TCG Crossover Management

View all funds holding Vistagen Therapeutics